- $4.1 BnWorld market, 2023
- $8.7 BnProjected, 2033
- 7.8%Growth a year (CAGR)
- 4,306Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$1.7 Bn
5.8% a year · 42% of the world -
2
China
$330 Mn
9.3% a year · 8% of the world -
3
Canada
$328 Mn
7.8% a year · 8% of the world -
4
Japan
$255 Mn
8.3% a year · 6.2% of the world -
5
Germany
$150 Mn
6% a year · 3.7% of the world -
6
France
$113 Mn
6.8% a year · 2.7% of the world -
7
UK
$107 Mn
5.8% a year · 2.6% of the world -
8
Brazil
$103 Mn
8.8% a year · 2.5% of the world -
9
Italy
$98 Mn
7.3% a year · 2.4% of the world -
10
Ecuador
$82 Mn
8.4% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
SpainBreast Cancer Diagnostic by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 44,284 papers since 2021
- Screening for Health-Related Social Needs at Mammography Encounters and Subsequent Breast Imaging Adherence. Journal of the American College of Radiology : JACR, 2026
- Directional interfacial charge transfer in NiFe heterostructure nanozymes for ultrasensitive cancer diagnostics. Journal of colloid and interface science, 2026
- [Socioeconomic inequalities in breast cancer in Germany: current situation and development over time]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2026
- Increasing Cancer Incidence in Iowa: A 22-Year Regional Comparative Analysis with the Seven Surrounding States. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026
- Integrating ToF-SIMS and machine learning reveals a mammary tumor-associated multi-ion signature. The Analyst, 2026
Compare Breast Cancer Diagnostic side by side
Key companies in Breast Cancer Diagnostic
Hologic, Inc.
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics, Inc.
Exact Sciences Corporation
Illumina, Inc.
Thermo Fisher Scientific Inc.
Abbott Laboratories
bioMérieux SA
Agilent Technologies, Inc.
Quick answers
How big is the Breast Cancer Diagnostic market?
The world Breast Cancer Diagnostic market was worth about $4.1 Bn in 2023 and is projected to reach $8.7 Bn by 2033, growing 7.8% a year (CAGR).
Which country has the largest Breast Cancer Diagnostic market?
The US is the largest of the 24 countries we cover, at $1.7 Bn in 2023. India grows fastest, at 10.8% a year.
How many clinical trials are running in Breast Cancer Diagnostic?
ClinicalTrials.gov lists 4,306 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Breast Cancer Diagnostic?
PubMed lists about 44,284 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.